Givaudan stock holds steady after revenue and margin gains

Givaudan (CH0010645932) is best read through its latest reported numbers: full-year 2025 sales reached CHF 7.41 billion, up 7.2% from 2024, while like-for-like sales rose 7.1% and EBITDA reached CHF 1.54 billion. The Swiss fragrance and flavor group also reported an EBITDA margin of 20.8% for 2025, giving the stock a clear profitability reference point on the SIX Swiss Exchange.

Revenue rose 7.2%

That 2025 revenue growth matters because it came on top of a year in which Givaudan still managed to expand the top line to CHF 7.41 billion. The company said like-for-like sales growth of 7.1% reflected broad-based demand across its core categories, a useful sign for a business that depends on steady volume and pricing discipline.

EBITDA of CHF 1.54 billion in 2025 and a 20.8% margin show that growth was not bought at the expense of profitability. For investors, that margin is often the more important figure than revenue alone, because it shows how much of the sales base turns into operating earnings.

Margin stayed above 20%

Givaudan also reported net income of CHF 1.09 billion for 2025, compared with CHF 1.03 billion in 2024. The increase is modest in percentage terms, but it confirms that the company converted stronger sales into more bottom-line profit rather than merely expanding the top line.

The mix of CHF 7.41 billion in sales, CHF 1.54 billion in EBITDA, and CHF 1.09 billion in net income gives a three-part view of the business: scale, operating leverage, and earnings retention. That combination is the main reason the stock is usually judged by margin stability as much as by growth.

Fragrance and flavor mix

The company’s performance is anchored in its flavors and fragrances portfolio, which serves food, beverage, personal care, and household applications. That end-market spread helps explain why 2025 sales growth could stay broad enough to support margin expansion and a billion-franc profit base.

A practical way to read Givaudan stock is to track whether the company can keep revenue growth close to the 7.1% like-for-like pace while defending the 20.8% EBITDA margin. If both hold, earnings quality remains high; if either slips, the valuation debate changes quickly.

Stock reference point

Givaudan stock trades on the SIX Swiss Exchange, and the latest available market value in this article is the company’s 2025 financial base rather than a live intraday quote. On that basis, the key figures to watch are CHF 7.41 billion in sales, CHF 1.54 billion in EBITDA, and CHF 1.09 billion in net income for 2025.